{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:35:48Z","timestamp":1784288148156,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.breast.2005.02.002","type":"journal-article","created":{"date-parts":[[2005,4,24]],"date-time":"2005-04-24T07:16:06Z","timestamp":1114326966000},"page":"290-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Histopathological and cell biological characteristics of ductal carcinoma in situ (DCIS) of the breast\u2014a comparison between the primary DCIS and subsequent ipsilateral and contralateral tumours"],"prefix":"10.1016","volume":"14","author":[{"given":"Ingrid","family":"Idvall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Ringberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e5ns","family":"\u00c5kerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e5rten","family":"Fern\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2005.02.002_bib1","first-page":"495","article-title":"Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case-control study in Sweden","volume":"10","author":"W\u00e4rnberg","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.breast.2005.02.002_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1677\/erc.0.0080033","article-title":"The management of ductal carcinoma in situ of the breast","volume":"8","author":"Skinner","year":"2001","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.breast.2005.02.002_bib3","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1097-0142(19821001)50:7<1309::AID-CNCR2820500716>3.0.CO;2-#","article-title":"Relationship of the extent of non-invasive disease to the frequency of occult invasion, multicentricity, lymph node metastases and short-term treatment failures","volume":"50","author":"Lagios","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2005.02.002_bib4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO;2-Y","article-title":"Pathologic findings from the National Adjuvant Breast Project (NSABP) eight-year update of protocol B-17","volume":"86","author":"Fisher","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2005.02.002_bib5","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199306033282201","article-title":"Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer","volume":"328","author":"Fisher","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2005.02.002_bib6","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1200\/JCO.2001.19.8.2263","article-title":"Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853","volume":"19","author":"Bijker","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2005.02.002_bib7","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1053\/ejso.1999.0919","article-title":"Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast","volume":"26","author":"Ringberg","year":"2000","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.breast.2005.02.002_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1054\/bjoc.2000.1618","article-title":"Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ","volume":"84","author":"Bijker","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2005.02.002_bib9","first-page":"215","article-title":"Evaluation of infiltrating ductal carcinomas with a DCIS component: correlation of the histologic type of the in situ component with grade of the infiltrating component","volume":"11","author":"Lampejo","year":"1994","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.breast.2005.02.002_bib10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0959-8049(97)10072-7","article-title":"Tumour grade does not change between primary and recurrent mammary carcinoma","volume":"34","author":"Millis","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2005.02.002_bib11","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/1097-0142(196412)17:12<1501::AID-CNCR2820171202>3.0.CO;2-P","article-title":"Bilateral primary breast cancer: a prospective clinicopathological study","volume":"17","author":"Robbins","year":"1964","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2005.02.002_bib12","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/1097-0142(19800815)46:4+<1026::AID-CNCR2820461327>3.0.CO;2-L","article-title":"Managing the remaining breast","volume":"46","author":"Leis","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2005.02.002_bib13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/1097-0142(19880715)62:2<412::AID-CNCR2820620228>3.0.CO;2-3","article-title":"Risk of contralateral breast cancer. Associations with histologic, clinical and therapeutic factors","volume":"62","author":"Horn","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2005.02.002_bib14","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/S0959-8049(98)00208-1","article-title":"Review. Evolving perspectives in contralateral breast cancer","volume":"34","author":"Dawson","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2005.02.002_bib15","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1053\/ejso.1999.0711","article-title":"Clinical and histological predictors of contralateral breast cancer","volume":"25","author":"Kollias","year":"1999","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.breast.2005.02.002_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF01961160","article-title":"Bilateral breast cancer: one disease or two?","volume":"19","author":"Dawson","year":"1991","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2005.02.002_bib17","first-page":"870","article-title":"Contralateral breast cancer: metastasis or second primary cancer?","volume":"83","author":"Broet","year":"1996","journal-title":"Bull Cancer"},{"key":"10.1016\/j.breast.2005.02.002_bib18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/1097-0142(19950715)76:2<250::AID-CNCR2820760215>3.0.CO;2-W","article-title":"Chromosome abnormalities in bilateral breast carcinomas. Cytogenetic evaluation of the clonal origin of multiple primary tumours","volume":"76","author":"Pandis","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2005.02.002_bib19","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0360-3016(02)02834-1","article-title":"Breast conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Center's experience","volume":"53","author":"Cutuli","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2005.02.002_bib20","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1002\/1097-0142(19810615)47:12<2928::AID-CNCR2820471232>3.0.CO;2-5","article-title":"Risk of subsequent contralateral breast carcinoma in a population of patients with in-situ breast carcinoma","volume":"47","author":"Webber","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2005.02.002_bib21","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0959-8049(01)00165-4","article-title":"Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics","volume":"37","author":"Ringberg","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2005.02.002_bib22","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/S0959-8049(03)00395-2","article-title":"Are cellular polarisation and mitotic frequency prognostic factors for local recurrence in patients with ductal carcinoma in situ of the breast?","volume":"39","author":"Idvall","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2005.02.002_bib23","doi-asserted-by":"crossref","unstructured":"Consensus Conference on the classification of ductal carcinoma in situ. Hum Pathol 1997;28:1221\u20134.","DOI":"10.1016\/S0046-8177(97)90193-3"},{"key":"10.1016\/j.breast.2005.02.002_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up","volume":"19","author":"Elston","year":"1991","journal-title":"Histopathology"},{"key":"10.1016\/j.breast.2005.02.002_bib25","series-title":"Statistical methods for rates and proportions","author":"Fleiss","year":"1981"},{"key":"10.1016\/j.breast.2005.02.002_bib26","series-title":"Multivariate statistical methods","author":"Morrison","year":"1976"},{"key":"10.1016\/j.breast.2005.02.002_bib27","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0959-8049(02)00666-4","article-title":"Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast","volume":"39","author":"Hopper","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2005.02.002_bib28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jnci\/92.4.313","article-title":"Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences","volume":"92","author":"Waldman","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.breast.2005.02.002_bib29","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0959-8049(05)80117-0","article-title":"Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?","volume":"28","author":"Barnes","year":"1992","journal-title":"Eur J Cancer"},{"issue":"suppl 1","key":"10.1016\/j.breast.2005.02.002_bib30","first-page":"S53","article-title":"HER-2\/neu (c-erb-B2) gene and protein in breast cancer","volume":"112","author":"Ross","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.breast.2005.02.002_bib31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/modpathol.3880288","article-title":"Breast cancer in the 21st century. Neu opportunities and neu challenges","volume":"14","author":"Schnitt","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/j.breast.2005.02.002_bib32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF00689717","article-title":"Maintenance of DNA-content and erbB-2 alterations in intraductal and invasive phases of mammary cancer","volume":"34","author":"Iglehart","year":"1995","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2005.02.002_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000163709","article-title":"Expression of c-erbB-2 in in situ and in adjacent invasive ductal adenocarcinomas of the female breast","volume":"60","author":"Maguire","year":"1992","journal-title":"Pathobiology"},{"key":"10.1016\/j.breast.2005.02.002_bib34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0093-7754(01)90133-2","article-title":"Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience","volume":"28","author":"Fisher","year":"2001","journal-title":"Semin Oncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977605000561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977605000561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:22:05Z","timestamp":1760775725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977605000561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0960977605000561"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2005.02.002","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histopathological and cell biological characteristics of ductal carcinoma in situ (DCIS) of the breast\u2014a comparison between the primary DCIS and subsequent ipsilateral and contralateral tumours","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2005.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}